Ryan Robb

5PUBLICATIONS

52CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer cell biology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 09, 2026

Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling.

|Jul 22, 2025

Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer.

Kristina Drizyte-Miller, Lars D Engstrom, Jeffrey A Klomp

|Jun 04, 2025

Hypoxic Gene Expression Signature as a Predictor of Recurrence and Mortality in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.

Nicholas J Eustace, Nikhil T Sebastian, Amy Webb

|Feb 11, 2025

Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

Jonathan M DeLiberty, Mallory K Roach, Clint A Stalnecker

|Mar 01, 2024

Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions.

Adam R Wolfe, Tiantian Cui, Sooin Baie

Pageof 1

Frequent Collaborators

Adrienne D Cox

Emanuel F Petricoin

Kirsten L Bryant

Khalilah E Taylor

Clint A Stalnecker

Kristina Drizyte-Miller

Channing J Der

Elisa Baldelli

Runying Yang

Mallory K Roach

Frequent Collaborators

Adrienne D Cox

Emanuel F Petricoin

Kirsten L Bryant

Khalilah E Taylor